Category: Cannabis
-
![MedMen’s (MMEN.C) pre-lim Q4, 2019 good news for the peepz suing them]()
MedMen’s (MMEN.C) pre-lim Q4, 2019 good news for the peepz suing them
If you’ve every tried suing someone who is insolvent, you know how frustrating that can be. U.S. cannabis retailer MedMen (MMEN.C) just announced its “unaudited systemwide revenue figures for Q4, 2019, which ended on June 29, 2019. Although there is an ominous black hole where news of the MMEN’s profitability might be, the August 13,…
-
Supreme Cannabis (FIRE.T) gives mouth-watering guidance as revenue expected to surge 449%
Shares of Supreme Cannabis (FIRE.T) surged on Tuesday after the premium cannabis grower gave mouth-watering guidance on fiscal fourth-quarter revenue growth, projecting supreme gains in 2020. The guidance comes on the heels of a solid fiscal third quarter, where Supreme Cannabis managed to grow net revenue by 382%. The company expects even bigger gains in…
-
Invictus MD Strategies (GENE.V) parts ways from KISS’ Gene Simmons, because duh
In news that will shock nobody who has been paying even the smallest sliver of attention, rock n’roll legend, KISS guitarist, and reality show nimrod Gene Simmons has stepped down from his position as Invictus MD Strategies’ (GENE.V) Chief Evangelist Officer, wishing the company whose stock he has probably finished selling off, a fond farewell.…
-
![Chemesis International (CSI.C) to market: “Chew on This”]()
Chemesis International (CSI.C) to market: “Chew on This”
On August 12, 2019 Chemesis International (CSI.C) announced that it will start manufacturing, packaging and distributing its own line of tobacco-free smokeless cannabis and hemp-derived chew in Puerto Rico and Canada and the U.S. A recent Equity Guru article described Chemesis as, “the Ichiro Suzuki of cannabis companies”. Suzuki seldom hit home runs, but was…
-
Sol Global (SOL.C): The only weed company I know that lists ‘divestments’ on its website
Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative journalists who write about nothing other than him, he’s got shareholders at various companies that have bought things from him screaming at him for taking their…
-
Supreme Cannabis (FIRE.T) goes on unexpected slide as ETFs re-calibrate, jump CannTrust (TRST.T) 50%
One of the big lessons both a public company CEO and a public company investor have to learn and remember always is, sometimes the market will take you out back and shoot you in the head and it’s not actually your fault, the gods determined that it just had to be done. Supreme Cannabis (FIRE.T)…
-
Abattis Bioceuticals (ATT.C): A grift building over several years until regulators couldn’t ignore it anymore
Several years ago, when Equity.Guru boss Chris Parry was writing at Stockhouse, he was called out to a new client – a company called Abattis Bioceutical (ATT.C). Abattis execs had just signed a marketing deal with Stockhouse to help tell their story to investors, and were excited for what might follow. As Parry tells it,…
-
![Bridgemark-linked Abattis (ATT.C) is getting booted off the CSE]()
Bridgemark-linked Abattis (ATT.C) is getting booted off the CSE
The Canadian Securities Exchange is not known for rigorous compliance protocols. However, it does have some standards, and cannabis health product company Abattis Bioceuticals (ATT.C) was unable to meet them. “The common shares of Abattis Bioceuticals Corp. will be delisted at the market close August 9, 2019,” stated the CSE. The CSE originally halted Abattis…
-
![Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)]()
Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine a product tuned in directly to your specific DNA to give you exactly what you need when you need it. That’s what Endocanna’s test kits offer. Endocanna’s kits provide personalized…
-
Aurora (ACB.T) predicts Q4 $100 million revenue – then the calculator jams
On Aug. 6, 2019 Aurora Cannabis (ACB.T) released “selected financial metrics” for Q4 2019 – which ended June 30, 2019. This gives investors a sneak peek, prior to official audited earnings, at some of the numbers. ACB’s Q4, 2019 Financial Projections: Last quarter Aurora reported $65.1 million net revenue, so the Q4 number is up…
